Using genetic research to treat inflammatory diseases Vienna centre of excellence in biomedicine harnesses basic research

Vienna centre of excellence in biomedicine harnesses basic research to quest for new therapies

Austrias first centre of excellence in biomedicine, Vienna based Bio Molecular Therapeutics (BMT), is going from strength to strength. With a workforce of over 60 and an annual budget of more than EUR 3.63 million, BMT is currently working on four major projects. The centre is researching into the genetic causes of chronic inflammatory diseases such as rheumatism and arteriosclerosis, inflammation of the gastro-intestinal tract, and disorders of the immune system.

BMT is a research association the only one of its kind in Austria that brings together leading university institutes, pharmaceutical companies, and domestic and foreign start-ups in order to achieve rapid transfers of research results from the laboratory to the patient. There is much to be gained, as the present lack of effective treatments for these widespread diseases is to blame for severe disabilities and about half of all fatalities. Although it was founded only two years ago, BMT can already point to palpable success in the form of international publications, patent registrations and promising new therapeutic approaches.

The decoding of the human genome is widely regarded as a milestone in the history of the biosciences. Less well known is the fact that the real purpose of these endeavours is to identify the genetic origins of diseases. BMT a line-up of ten commercial and scientific partners with complementary areas of expertise is in the forefront of these efforts. The chosen organisational and managerial set-up of the centre is aimed at ensuring that relevant research results are applied, in the interests of patients.

BMTs operational partners are the Medical Faculty of the University of Vienna (the Institute of Vascular Biology and Thrombosis Research, the Institute of Immunology, and the Department of Immunodermatology and Infectious Skin Diseases, University Clinic

Contact: Gudrun Baumann
PR&D Public Relations for Research & Development

Page: 1 2 3

Related biology news :

1. Using statistics to decipher secrets of natural mutation
2. Using science to restore habitat for declining species
3. Using soils as filters to prevent crypto from moving to the groundwater
4. Using a companion crop to control weeds organically
5. Using plants and microbes to purify polluted industrial wastewater
6. Using GPR to estimate tree root biomass
7. Using computational power tools to bolster systems biology
8. Using RNA interference to tune gene activity in stem cells
9. Using sewage sludge as fertilizer
10. Using the oceans living light shows to fight terrorism or track the planets most massive migration
11. Using brain activity to identify risk for disorders

Post Your Comments:

(Date:2/1/2020)... ... 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year in ... HCC is the 5th most common cancer and the 2nd leading cause of cancer ... incidence of HCC, while China has half of all patients suffering from liver cancer. ...
(Date:1/29/2020)... ... 29, 2020 , ... VGXI, a world leading contract manufacturer ... vaccine against the novel coronavirus (2019-nCoV) that has recently emerged in Wuhan, China ... million from the Coalition for Epidemic Preparedness Innovations (CEPI) will fund the vaccine ...
(Date:1/27/2020)... DIEGO (PRWEB) , ... January 27, 2020 , ... ... Thorne as Chairman. Thorne is a noted investor, tech entrepreneur, and former senior ... as Executive Chairman of Broadline Capital, the global alternative investment firm. , ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery ... Southern Midwest Region Industrial and Institutional (I&I) Account Manager. Darrell will focus on ... , Darrell brings over 30 years of sales experience working across multiple different ...
(Date:1/10/2020)... ... January 09, 2020 , ... GenScript Biotech Corp., ... Biotech Global Forum on Jan. 14 in San Francisco, coinciding with the JP ... and the Booming China Market," will feature gene and cell therapy leaders in ...
(Date:1/7/2020)... Mass. (PRWEB) , ... January 06, 2020 , ... ... for a Digital World at The Fletcher School at Tufts University, is pleased ... Sloan Foundation. The grant will be administered by Tufts University, and will help ...
(Date:12/30/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... December ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... its new SIMS Version 1.11.19 21 CFR Part 11 compliant software program specific ...
Breaking Biology Technology:
Cached News: